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Abstract: Lymphedema of the arm is the most common and impairing complication after breast 
cancer surgery with axillary lymph node dissection (ALND). Our prospective study evaluated 
the effect of two different surgical techniques for ALND on postoperative morbidity. Patients 
were scheduled to undergo ALND. Patients in group 1 (n = 17) underwent the most common and 
standard technique of ALND, which uses sharp dissection of the tissue and subsequent electro-
coagulation of bleedings. Patients in group 2 (n = 17) underwent a modified standard technique 
of ALND with clamping and ligatures of all resection margins. Postoperative wound secretion 
was quantified and patients were followed up for 6 months to assess long-term morbidity. 
The variations in surgical technique had no significant influence on the outcome variables. 
However, patients in group 2 showed a tendency to less wound secretion (713 versus 802 mL; 
P = nonsignificant), a decreased rate of immediate postoperative seromas (11.8 versus 23.5%; 
P = nonsignificant) and less lymphedema after 3 months (29.4 versus 41.2%; P = nonsignificant). 
Moreover, the number of resected lymph nodes correlated with the total amount of drained fluid 
(P = 0.006), the duration of the drain (P = 0.015), and the risk for the development of lymphedema 
after 3 months (P = 0.016). The described variations in surgical technique had no influence on 
the outcomes of the patients. The number of resected axillary lymph nodes remains the most 
important risk factor for treatment-related morbidity. Therefore, a well-balanced choice of the 
extent of the axillary dissection should be the surgeon’s main concern.
Keywords: breast cancer, axillary dissection, lymphedema, morbidity
Lymphedema of the arm is a major complication that women face after breast cancer 
surgery with axillary lymph node dissection (ALND). The literature describes an 
incidence between 2% and 51%, based on either subjective or objective findings.1–4 
The development of lymphedema depends on treatment-related factors, such as the 
radicalness of surgery. Other known risk factors are adjuvant systemic chemotherapy 
or adjuvant radiation (and the combination of both), wound infections, the number of 
metastatic lymph nodes (LNs), obesity, hypertension, the patient’s age at diagnosis, 
and excessive use of the limb after surgery.5
Today, sentinel node biopsy (SNB) is the standard therapy for women that are 
preoperatively staged with a negative nodal status.6 The precision of histological 
staging by SNB is very high, and it significantly minimizes postoperative morbidity.5 
If axillary metastases are suspected in the clinical examination, or if there was neo-
adjuvant therapy, the success of SNB may be impaired. These patients should still 
undergo conventional ALND, which is a more extensive intervention compared with 
SNB. In these cases, it is recommended to explore level I (from the lateral side of the 
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small pectoralis muscle over the thoracodorsal nerve and 
vessels to the lateral chest wall) and level II (resection of 
the fatty tissue of the axilla and underneath the pectoralis 
minor muscle). The aim of ALND is to remove all clini-
cally apparent manifestations of the disease and to dissect 
at least ten lymph nodes for pathologic evaluation to stage 
the axilla accurately. Abundant surgery beyond level I and II 
nodes should be avoided, and axillary dissection is extended 
to level III nodes only if gross disease is apparent in level I 
or II nodes or if there are clinically suspicious lymph nodes 
in level III nodes.7 The traditional ALND procedure implies 
a significant increase in morbidity, such as lymphedema or 
paresthesia of the arm.8
Regarding the surgical technique of ALND, the tissue 
is usually resected using a scalpel or either conventional or 
bipolar scissors, or it is gently disrupted using other instru-
ments. Larger blood vessels are either clamped and ligated or 
  coagulated. However, small lymphatic vessels and capillary 
blood vessels are not completely sealed. Alternatively, in 
order to close these small vessels efficiently, tissue bridges 
can be dissected by clamping and ligation (ie, sutures).
The objective of our study was to compare two different 
standard techniques for ALND that involved either cutting 
and coagulation or clamping and ligation with respect to post-
operative morbidity. We hypothesized that the consequent 
occlusion of small vessels with ligatures may have clinical 
benefits for the patient.
Methods and materials
Study design
Our study was carried out between January 2007 and October 
2008 at the Breast Cancer Center of the University Hospital 
of Saarland, Homburg/Saar, Germany.
Two different standard surgical techniques for ALND 
were compared in group 1 and group 2, respectively.
In group 1, the tissue was dissected with conventional 
scissors or gently disrupted with other instruments. The 
vessels were coagulated whenever bleeding occurred, and 
only large vessels were clamped and ligated. As a matter 
of course, the relevant anatomical structures (ie, the thora-
codorsal nerve and thoracodorsal vessels, the long thoracic 
nerve, the intercostobrachial nerves, and the axillary vein) 
were thoroughly identified and preserved. In this technique, 
small lymphatic vessels and capillary blood vessels are not 
completely sealed. This surgical technique is the most com-
monly used in ALND.9
In group 2, the axillary tissue was carefully explored 
without cutting or disrupting the lymphatic vessels, 
blood vessels, or connective tissue structures. The fatty tissue 
was gently mobilized and separated from more solid connec-
tive tissues and relevant anatomical structures (see above). 
The remaining tissue bridges were then clamped, cut through 
with conventional scissors, and ligated. For the ligature, we 
used a midterm braided and coated synthetic absorbable 
material (Safil® Violet 3/0; B Braun Melsungen AG, Inc, 
  Melsungen, Germany). This procedure was intended to 
occlude even small lymphatic vessels and capillary blood 
vessels.
Our study cohort was recruited from patients who attended 
our breast cancer center seeking management of their disease. 
All patients were diagnosed and treated according to standard 
protocols.7,10 Patients with invasive breast cancer who were 
scheduled to undergo ALND due to clinically suspicious 
lymph nodes were regarded as suitable for our study. Patients 
with a history of breast or axilla surgery, orthopedic problems 
in the arm or shoulder joint, inflammatory conditions of the 
breast, or skin disorders were excluded. Patients who met the 
inclusion criteria and who agreed to be enrolled in our study 
were randomized to be treated either in group 1 (ALND based 
on cutting and coagulation, n = 17) or in group 2 (ALND based 
on clamping and ligation, n = 17). The surgical procedures 
were performed by the authors KE and MD.
As both techniques for ALND represent standard surgical 
techniques, the responsible ethics committee did not require 
additional approval for our study design. All patients gave 
their written, informed consent for the selected surgical 
procedure.
Postoperative assessment  
and study endpoint
During the surgical procedure, all patients received a 
12 gauge suction drain (Redon type).11
The primary study objective was to measure the amount 
of postoperative wound secretion on a daily basis. In addi-
tion, data was generated concerning the composition of the 
drained fluid (protein content and hemoglobin) 24 hours 
after surgery. Postoperative treatments, such as dressings, 
  infusions, mobilization, and physical therapy were carried 
out identically in both groups. The drain was removed as 
soon as the amount of secretion was #30 mL within 24 hours 
or #50 mL within 24 hours on two consecutive days.
The secondary study objective was to determine the 
rate of lymphedema after 3 and 6 months. As a matter of 
fact, none of the existing rating scales for lymphedema 
have been formally validated.12 Our study defined arm 
lymphedema as a difference in the circumference of the   
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arms of at least 4 cm at the point of greatest visible difference. 
It included subjective complaints or the necessity for medical 
treatment, such as manual compression lymphatic massage, 
compression garments, or bandaging. This definition corre-
sponds to a lymphedema grade 2 or higher according to the 
late effects toxicity scoring system of the EORTC.13
Adjuvant treatment was carried out according to the com-
mon standards: All patients who were treated with breast-
conserving surgery received adjuvant radiotherapy of the 
breast. None of the patients received axillary radiotherapy. 
Adjuvant chemotherapy was applied whenever it was 
indicated. The route of the administration of chemotherapy 
was either intravenous in the contralateral arm or in an 
implanted port on the contralateral side.
Statistical analysis
Excel® 2007 (Microsoft Corporation, Redmond, WA) was 
used for data collection. Statistical analysis was performed 
by the author SN and validated by SW. The analysis was 
performed with MedCalc® 11.6 statistical software (MedCalc 
Software bvba, Mariakerke, Belgium).
Results are presented as the mean ± standard deviation 
(SD), counts, and/or percentages with 95% confidence inter-
vals (95% CI) where applicable. A Student’s t-test was used 
for comparison of means for the numerical data. Categorical 
data were compared using Fisher’s exact test for univariate 
distributions and Yates’s chi-square test for multivariate 
distributions. Odds ratios (OR) were used to explore risk 
factors further for postoperative morbidity. For correlations, 
we applied Pearson’s product moment correlation. Statistical 
significance was assumed as P , 0.05 for all tests.
Results
All patients were treated according to the randomized study 
protocol, and there were no protocol violations. None of 
the patients dropped out, and all patients were available for 
the planned follow-up after 3 and 6 months. Therefore, all 
34 patients were included in the analysis.
Concerning the demographic data, the tumor stage, and 
the details about the surgical procedure, there were no sig-
nificant differences between the groups. The detailed results 
are shown in Table 1.
After surgery, the total amount of drained fluid was 
802 ± 546 mL in group 1 and 713 ± 382 mL in group 2. 
Despite the tendency, the difference was not significant 
(P = 0.58). Furthermore, regarding the daily discharge of 
fluid over time, the course of both curves was nearly identical 
(Figure 1). Consequently, the duration of the suction drain 
was identical in both groups with 10.1 ± 4.0 days in group 1 
and 9.5 ± 3.9 days in group 2 (P = 0.64).
When comparing the protein and hemoglobin content of 
the drained fluid 24 hours after surgery, we found a protein 
concentration of 41.3 ± 7.3 g/L in group 1 and 43.2 ± 8.1 g/L 
in group 2. Concerning hemoglobin levels, the content was 
2.4 ± 1.3 g/dL in group 1 and 2.7 ± 1.8 g/dL in group 2. 
These differences were not significant (P = 0.48 and P = 0.57, 
respectively).
There was a tendency for more postoperative seroma 
requiring interventions in group 1 (23.5%) compared with 
group 2 (11.8%). The odds ratio for this complication was 
2.31 (95% CI: 0.36–14.72) and failed to be statistically 
significant (P = 0.38). We also found a tendency for more 
lymphedema after three months in group 1 (41.2%) compared 
Table 1 Group comparison (mean ± standard deviation, range, or rate)
Group 1 
(cutting and coagulation)  
(n = 17)
Group 2 
(clamping and ligation)  
(n = 17)
Age (years) 59.4 ± 12.4 (45–84) 60.3 ± 12.1 (39–83)
BMI (kg/m²) 25.0 ± 2.0 (21–40) 28.2 ± 5.2 (19–39)
Blood pressure preoperative (systolic/diastolic, mmHg) 129 ± 14 / 76 ± 11 (100–170/55–95) 127 ± 16 / 75 ± 11 (80–155/60–100)
BCT (%, n) 64.7% (11/17) 64.7% (11/17)
Total duration of surgery (min) 117 ± 36 127 ± 54
pT1 (%, n) 35.3% (6/17) 52.9% (9/17)
pT2 (%, n) 58.8% (10/17) 41.2% (7/17)
pT3/pT4 (%, n) 5.9% (1/17) 5.9% (1/17)
CT (%, n) 76.5% (13/17) 76.5% (13/17)
RT if BCT (%, n) 100% (11/11) 100% (11/11)
PMRT (%, n) 33.3% (2/6) 33.3% (2/6)
ET if HR+ (%, n) 100% (13/13) 100% (14/14)
Note: Differences between group 1 and group 2 are statistically not significant. 
Abbreviations: BCT, breast-conserving therapy; CT, chemotherapy; ET, endocrine therapy; HR+, hormone responsive; PMRT, postmastectomy radiation therapy; pT, 
pathologic tumor stage; RT, radiation therapy.
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Figure 1 Comparison of the amount of drained fluid drained from the axilla between group 1 (surgery based on cutting and coagulation) and group 2 (surgery based on 
clamping and ligatures).
Note: The difference between the groups was not statistically significant.
Table 2 Comparison of the outcome variables between group 1 and group 2 (mean ± standard deviation, range, or rate)
Group 1 
(cutting and coagulation)  
(n = 17)
Group 2 
(clamping and ligation)   
(n = 17)
Total number of resected lymph nodes (n) 11.1 ± 6.4 13.6 ± 5.7
Number of resected lymph nodes level I (n) 6.8 ± 4.5 9.8 ± 4.1
Number of resected lymph nodes level II (n) 3.4 ± 2.5 3.0 ± 2.8
Number of resected lymph nodes level III (n) 0.9 ± 1.7 0.8 ± 1.0
Primary outcome variables
Total amount of drained fluid (mL) 803 ± 546 (160–1480) 712 ± 382 (110–2270)
Duration of suction drain (days) 10.1 ± 4.0 (5–14) 9.5 ± 3.9 (4–19)
Immediate seroma after removal of suction drain (%) 23.5 11.8
Secondary outcome variables
Lymphedema after 3 months (%, n) 41.2 (7/17) 29.4 (5/17)
Lymphedema after 6 months (%, n) 47.1 (8/17) 47.1 (8/17)
Other morbidity concerning the axillary region  
after 3 and 6 months (%, n)
0 (0/17) 0 (0/17)
Additional data
Total protein content of drained fluid (g/L) 41.3 ± 7.3 (25–52) 43.2 ± 8.1 (30–59)
Hemoglobin content of drained fluid (g/dL) 2.4 ± 1.3 (0.3–4.6) 2.7 ± 1.8 (0.5–6.1)
Note: Differences between group 1 and group 2 are statistically not significant.
with group 2 (29.4%). This difference was not significant 
either (OR = 1.68, 95% CI: 0.41–6.96; P = 0.47). After six 
months of observation, there was no difference regarding the 
rate of arm lymphedema in both groups (47.1% versus 47.1%, 
respectively; P = 1.00). No other complications beyond 
seroma and/or arm lymphedema occurred in the two groups 
(eg, infections, reduction of the range of motion, chronic 
pain). The results are summarized in Table 2.
Because the variations in surgical technique showed 
only a nonsignificant influence on morbidity, we further 
explored the known, classical risk factors in our study 
collective (n = 34) and focused on the number of resected 
LNs as an indicator of the radicalness of the surgical 
procedure.
There was a strong correlation between the number of 
resected LNs, the total amount of drained fluid (r = 0.45; 
P = 0.006), and the duration of the suction drain (r = 0.41; 
P = 0.015). Both parameters significantly increased according 
to the number of resected LNs (Figure 2).
Regarding the patients who suffered from seroma of the 
axilla after removal of the drain, there was no difference in 
the number of resected LNs (12.0 versus 11.7 LNs; P = 0.92). 
On the other hand, patients who developed arm lymphedema 
after 3 or 6 months had a higher number of resected LNs 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
124
Wojcinski et alCancer Management and Research 2012:4
compared with patients who did not experience lymphatic 
problems (after 3 months 15.2 versus 9.9 LNs; P = 0.016; 
after 6 months 13.9 versus 9.8 LNs; P = 0.054, trend towards 
statistical significance).
Because both the protein concentration and hemoglobin 
concentration increased with an increasing number of resected 
LNs, there was also a correlation between the number of 
resected LNs and the quality of the drained fluid (r = 0.33; 
P = 0.054, trend and r = 0.36; P = 0.045) (Figure 3). On the 
other hand, the composition of the fluid was not suitable as 
a predictor of the development of arm lymphedema. In both 
patient groups (those with and those without lymphedema), 
the distribution of protein and hemoglobin in the fluid was 
not different (for protein 42.9 versus 41.7 g/L; P = 0.68; for 
hemoglobin 2.56 versus 2.43 g/dL; P = 0.53, trend).
Discussion
Our study attempted to determine whether immediate post-
operative and long-term morbidity after axillary dissection 
could be reduced by variations in surgical technique. 
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Figure 2 Positive correlation between the number of resected LNs and the total amount of fluid drained from the axilla (P = 0.006; A) and a positive correlation between 
the number of resected LNs and the duration of the drain (P = 0.015; B).
Abbreviation: LNs, lymph nodes.
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Figure 3 Positive correlation between the number of resected LNs and the protein concentration in the drained fluid (P = 0.054; A) and a positive correlation between the 
number of resected LNs and hemoglobin in the drained fluid (P = 0.045; B).
Abbreviation: LNs, lymph nodes.
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Although SNB constitutes a standard procedure in breast 
cancer, women with clinically suspicious LNs or histologi-
cally confirmed metastases cannot benefit from this gentle 
procedure.6 However, these women may profit from a less 
aggressive surgical technique for ALND in terms of reduced 
morbidity without impairment of the oncological outcome.
Concerning the relevant parameters, throughout the 
follow-up time of 6 months, we found no statistically sig-
nificant differences related to the surgical technique used. 
Patients who need to undergo ALND for histologically proven 
or suspected metastatic LNs must still accept a high risk of 
arm lymphedema, which was a maximum of 47.1% in our 
study. Generally, the rate of arm lymphedema in our study 
was quite high, although it was within the reported range 
quoted in the literature, which describes arm lymphedema in 
2% to 51% of patients.2–4 This high rate might be due to the 
focus on patients with clinically suspicious lymph nodes in 
addition to the relatively strict definition of arm lymphedema 
applied in our study. However, because of the high rate of 
lymphedema, other techniques of ALND and combinations 
of different techniques should be further investigated.
The technique that was applied to the patients in group 2 
results in a higher amount of foreign material left in the body. 
On the other hand, the electrocoagulation technique used in 
group 1 causes more thermal trauma to the tissue. Comparison 
of these two types of tissue irritation in our study showed that 
the total amount of fluid was lower in group 2 than in group 1. 
The rate of immediate postoperative seroma was also reduced 
although the differences were statistically not significant. 
However, there were slightly more pT2 tumors in group 1 
(58.5% versus 41.2%, not significant) which might influence 
this outcome variable because of the more extensive surgery to 
the breast. On the other hand, this result might suggest a minor 
influence of the surgical technique on recovery after ALND 
although we were not able to prove this effect in our study.
In 2006, Agrawal et al demonstrated that electrocautery 
dissection causes thermal trauma and results in increased 
volumes of seroma.14 Therefore, the technique of clamping 
and ligature is an opportunity to reduce thermal trauma of 
the tissue without presenting known disadvantages.
In 1999, Bonnema et al investigated the composition of 
the axillary fluid discharge after ALND. The authors showed 
that on the first day after ALND, the serous fluid contained 
higher amounts of blood particles and then changed to a 
lymphatic-like fluid.15 In our study, we did not repeat the 
analysis of the fluid over time, but assessed the fluid 24 hours 
after surgery and correlated the results with the surgical 
technique and the risk for the development of lymphedema. 
There was no correlation in this regard. All patients had a 
similar composition of the fluid.
Interestingly, we found a correlation between the radi-
calness of the surgery, expressed as the number of resected 
LNs, and the amount of blood particles and protein in the 
fluid. The hemoglobin content rose with more extensive 
ALND, which can be explained by more bleeding related to 
the larger region that was surgically explored. The protein 
content of the drained fluid averaged about 40 g/L, fulfilling 
the definition of an exudation. Exudates are usually caused 
by tissue trauma or inflammation, whereas transudates are a 
consequence of increased hydrostatic pressure or decreased 
colloid oncotic pressure in the vessels. Therefore, the tissue 
trauma associated with more resected LNs may result in 
an increased protein content of the wound secretion, as 
we demonstrated in our study. Although these effects are 
significant and have plausible physiological explanations, 
the analysis of the wound secretion does not permit risk 
prediction for the development of lymphedema.
Regarding our entire study population, we found a sig-
nificant correlation between the number of resected LNs and 
the total amount of drained fluid, resulting in a significant 
effect on the duration of wound drainage. Furthermore, the 
number of resected LNs had an impact on the subsequent 
development of arm lymphedemas although this difference 
only showed a trend towards statistical significance, which 
may be due to the small sample size. After surgery, there 
are fewer lymph nodes and lymphatic vessels to process 
the lymphatic fluid. Consequently, lymphatic fluid may 
accumulate and cause swelling along the arm. If just a few 
nodes are removed (ie, SNB), the risk for lymphedema is 
lower and may be a temporary condition, but if most lymph 
nodes are removed (ie, ALND), lymphedema is more likely 
and may be a permanent problem. With respect to this impor-
tant result, the variations in the surgical technique had no 
effect on the morbidity of the patients in our study.
The main limitation of our study is the relatively small 
sample size (n = 34), with only 17 probands in each group. 
Therefore, our study is unable to answer fully the question 
of an optimal surgical technique. If we used our primary 
outcome variables to calculate the necessary sample size 
in order to achieve a power of 0.80 with a type I error rate 
of 0.05, a subsequent study using ten times the number of 
patients would be required.
Nevertheless, our results suggest that the variations 
in surgical technique have only limited influence on the 
immediate postoperative and long-term morbidity of the 
patient and that the radicalness of the surgery, reflected in 
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the number of resected LNs, remains the main risk factor as 
reported previously.16
Another limitation is the short follow-up period of 6 months. 
Three months after surgery, the rate of arm lymphedema was 
41.2% in group 1 and 29.4% in group 2. After 6 months, 
both groups exhibited the same rate of lymphedema (47.1%). 
  Furthermore, arm lymphedema is known to occur occasionally, 
even many years after surgery. Lymphedema is a complex 
side effect of breast cancer treatment and has a crucial impact 
on the patient’s quality of life. Patients report pain, increased 
circumference, and limited function of the arm. Furthermore, 
there is an increased risk for subsequent severe infections. 
Finally, lymphedema also impairs psychovegetative health.17 
Therefore, an even longer follow-up would be necessary to 
detect all lymphedemas in both groups precisely. Nevertheless, 
in current studies it is common to evaluate the rate of lym-
phedema only 6 months after surgery.1
Conclusion
Our results demonstrate that the number of resected axillary 
LNs remains the most important risk factor for treatment-
related morbidity. The choice of surgical technique had no 
influence on the outcome of the patient. Therefore, a well-
balanced choice of surgical technique based on the extent of 
the axillary dissection and oncological considerations should 
be the main concern of the surgeon.
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